Current Issue

Cover Story

A New Starting Point
As health care providers worldwide work to reestablish a firm operational footing, AHRA has rolled out the Imaging Innovation Council, a collaborative that addresses gaps and opportunities within the imaging community.

Featured Articles

Don’t (Need to) Hold Your Breath
Thanks in part to heightened awareness and improved technology, liver MRI screening has moved closer to the forefront of the imager’s repertoire.

Sign of the Times
In a renewed effort to get out in front of the pandemic, radiologists are sharpening their expertise in recognizing COVID-19 on 3D ultrasound images of the pleural lining. 

Dose of Reality
Education and communication figure prominently in the effort to reduce exposure to unnecessary radiation dosage. Radiology Today tracks the emerging trends. 

Web Exclusive l View Archives
Secure Investment: Finding Funding for Health Care Cybersecurity
By Brad Kincaid, MD; Fatima Khan, BS; and Alex Merkulov, MD

History
A 56-year-old woman with a history of phyllodes tumor (PT) in the left breast presented with a new palpable left breast mass. Her breast-related history is extensive. Bilateral breast implants were placed in 2009. In 2013, the patient had a left breast excisional biopsy for a concerning mass, and pathology identified a cellular fibroadenoma with epithelial ductal hyperplasia. In 2015, an additional palpable left breast mass was evaluated and consistent with high-grade PT. She underwent a skin-sparing left mastectomy. Postsurgical pathology revealed two separate high-grade PTs measuring 6 cm and 3 cm with negative margins. Radiation therapy was not performed. Continue reading »
Physician Recruitment Center